Two New Drugs Added to Heart Failure Clinical Practice Guideline

Share this content:
Two New Drugs Added to Heart Failure Clinical Practice Guideline
Two New Drugs Added to Heart Failure Clinical Practice Guideline

MONDAY, May 23, 2016 (HealthDay News) -- An updated clinical guideline adds two new types of drugs to the list of treatment options for heart failure. The updated guideline was published online May 20 in the Journal of the American College of Cardiology, Circulation, and the Journal of Cardiac Failure.

The two new treatments in the updated guideline are an angiotensin receptor-neprilysin inhibitor (valsartan/sacubitril), sold as Entresto, and a sinoatrial node modulator (ivabradine), sold as Corlanor, according to the American College of Cardiology, the American Heart Association, and the Heart Failure Society of America.

Previously recommended drugs for these patients include angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, beta blockers, and diuretics.

"Treatment options for patients with heart failure have expanded considerably. There is more hope than ever before for patients with heart failure," guideline update committee vice chair Mariell Jessup, M.D., of the University of Pennsylvania School of Medicine in Philadelphia, said in a news release from the heart groups. "These guideline recommendations will serve as a tool to guide the choice of therapy and, in turn, improve outcomes."

Several authors disclosed financial ties to the pharmaceutical industry.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Potentially Unsafe Med Scripts Up for Dual Users With Dementia

Potentially Unsafe Med Scripts Up for Dual Users ...

Rates of PUM are higher among veterans with dementia using VA-Medicare Part D system

Menopausal Status Linked to Faster Lung Function Decline

Menopausal Status Linked to Faster Lung Function Decline

Transitional, postmenopausal women have increases in adjusted mean forced vital capacity decline

Social Media Rarely Used by Plastic Surgeons

Social Media Rarely Used by Plastic Surgeons

6 percent of posts about plastic surgery by plastic surgeons; 37 percent of these self-promotional

is free, fast, and customized just for you!

Already a member?

Sign In Now »